Tackling Climate Risks and Nature Dependencies for a Healthy Future for Pharma

The pharmaceutical industry accounts for over 4% of global emissions, with around 80% of medicines derived from plants or inspired by nature. The sector’s dependencies on natural ecosystems pose substantial risks from regulatory to operational. While industry leaders recognize the need for robust climate strategies, many overlook the importance of nature. By understanding your company’s reliance and impacts on nature, and accelerating action, pharma companies can mitigate environmental risks and drive resilience across the business. New frameworks and tools now make it easier for companies to quantify their impacts and set targets to reverse nature loss.

This session will share insights on leveraging frameworks like SBTN and TNFD to create sustainability strategies that integrate nature and climate. Topics include mitigating nature loss to bolster climate efforts and integrating sustainability into business models. Don’t miss this opportunity to learn about the vital role of sustainability in the pharma industry’s future.